GSK reports positive data for experimental blood cancer drug

GlaxoSmithKline received a boost for its oncology research on Thursday, as it reported further positive data from a study of its experimental drug for blood cancer.

from Reuters: Health https://ift.tt/2JwqWrb
via IFTTT

• Tweet
• Share
• Share
• Share
• Share